Report Overview:
Near-infrared fluorescence (NIRF) imaging is a medical imaging technique that employs near-infrared (NIR) light to capture images of tissue and structures inside the human body. This method uses fluorescence imaging agents that can be excited by NIR light (typically with wavelengths greater than 760 nm). These agents, when exposed to NIR light, emit fluorescence, allowing the visualization of tissue deposition, enabling surgeons to detect abnormalities and guide surgical interventions. NIRF imaging has been gaining popularity for its non-invasive, high-precision capabilities in real-time during various surgeries, such as cardiovascular surgery, cancer surgery, gastrointestinal surgery, and plastic and reconstructive surgery.
The market for NIRF imaging devices has witnessed considerable growth, driven by increasing adoption in clinical settings, improvements in imaging technologies, and rising demand for precision medicine. The ability of NIRF imaging to enhance visualization and surgical outcomes makes it a preferred choice in complex surgical procedures.
Market Value:
The global Near-infrared Fluorescence (NIRF) Imaging Device market was valued at USD 583.70 million in 2024 and is projected to reach USD 1325.89 million by 2032, exhibiting a remarkable compound annual growth rate (CAGR) of 10.80% during the forecast period.
By Types:
• Open Surgery
• Laparoscopic Surgery
By Applications: Cardiovascular Surgery
Cancer Surgery
Gastrointestinal Surgery
Plastic and Reconstructive Surgery
Key players include:
• Stryker
• Karl Storz
• Olympus
• Medtronic
• Leica Microsystems (Danaher)
• Shimadzu
• Hamamatsu
• Mizuho Medical
• Including or Excluding key companies relevant to your analysis.
